Restricted accessResearch articleFirst published online 1979-11
A Single Dose Placebo-Controlled Study to Assess the Effectiveness of Adding a Muscle Relaxant to a Compound Analgesic in the Treatment of Tension Headache
A patient-assessment of pain relief over 4 hours following a single dose of a compound analgesic has shown that 78% of patients achieve satisfactory relief of pain due to tension headache and that this response is enhanced by the addition of chlormezanone, an agent with reported anxiolytic and muscle relaxant actions. Side-effects were minor in nature.
Get full access to this article
View all access options for this article.
References
1.
CarloP E (1955) Plasma levels after the oral administration of acetylsalicylic acid and N-acetyl-p-aminophenol in different forms of human subjects. Journal of the American Pharmaceutical Association Scientific Edition44, 396.
2.
FinnesonB E (1969) Prognosis and management of Pain Syndromes. 2nd EdPhiladelphia.
3.
GanzS E (1959) Clinical evaluation of a new muscle relaxant (chlormezanone). Journal of the Indiana Medical Association52, 1134.
4.
HedgesAKayeC M (1973) A comparison of the absorption of two formulations of paracetamol. Journal of International Medical Research1, 548.
5.
LockettM FPatelU G (1961) The analgesic action of chlormezanone. Journal of Pharmacy and Pharmacology, 13th September, 536.
6.
McCheaneyE W (1967) Metabolism of chlormezanone in man and laboratory animals. Biochemical Pharmacology16, 813.
7.
WilkinsonM (1971) Migraine – treatment of acute attack. British Medical Journal2, 754.
